Authorizes veterinarians to establish a client-patient relationship through electronic means, subject to limitations and requirements such as Vet making a good faith effort to determine if care should be provided through telemedicine instead of in person.
This bill amends Rhode Island law to rename drug court as recovery court and establish a new position for a drug recovery court magistrate within the superior court. The magistrate would be appointed by the presiding justice with senate approval, serve ten-year terms, and preside over adult offenders charged with non-violent drug-related offenses who are deemed drug-addicted. Key provisions include the magistrate's authority to enforce program conditions, impose incarceration for violations, and make final decisions on program admission and participant eligibility based on specific criteria. The bill also grants the magistrate powers to handle matters related to sexual offender registration and allows for appeals of magistrate orders to a superior court justice.
This bill amends Rhode Island law to rename drug court programs as recovery court, expanding eligibility to include non-violent offenses beyond just drug-related charges. The legislation creates a new position of drug recovery court magistrate within the superior court, who will preside over adult recovery court programs that combine court authority with therapeutic treatment plans for drug-addicted defendants. Key provisions include establishing a ten-year appointment term for magistrates, defining screening criteria for program admission, and granting magistrates the power to impose incarceration for violations of court conditions. The bill also clarifies that participants must sign contracts outlining program expectations and allows for appeals of magistrate orders to a superior court justice.
This bill strengthens oversight of pharmacy benefits managers and pharmacy benefit management services in Rhode Island by requiring them to register with the Department of Business Regulation and file detailed public reports on their financial arrangements and corporate relationships. It mandates that these managers cannot stop pharmacists from telling patients about drug costs or alternative purchasing options, and it prohibits charging copayments that exceed the actual amount the pharmacy receives for dispensing a prescription. Additionally, the law requires a streamlined appeal process for pharmacies to resolve disputes over multi-source generic drug pricing within fifteen days. These changes aim to increase transparency and ensure fair competition in how prescription drug benefits are administered.
Requires pharmacy benefit managers to apply for certificate of authority from DBR to operate such a business in this state. Empowers the health insurance commissioner to oversee pharmacy benefit managers and penalize violations.
Prohibits healthcare providers and health plans from denying the payment of a medical bill, solely because the bill may have arisen from a third-party claim.
Requires that reimbursement rates for certified mobile response and stabilization services be equal to or greater than the prevailing integrated state Medicaid rate for mobile response and stabilizations services.
Requires pharmacy benefit managers to apply for certificate of authority from the office of health insurance commissioner to operate such a business in this state and empowers the commissioner to oversee pharmacy benefit managers and penalize violations.
This bill strengthens oversight of pharmacy benefits managers in Rhode Island by requiring them to register with the state and submit detailed annual reports about their financial relationships with insurers. It prohibits these managers from forcing pharmacies to substitute generic drugs without prescriber approval and bans them from stopping pharmacists from sharing pricing information with patients. The legislation also prevents pharmacy benefits managers from charging copayments that exceed what pharmacies are paid and mandates a clear appeals process for disputes over drug pricing. These changes directly affect pharmacy benefits managers, insurers, pharmacies, and patients who use prescription drug coverage in the state.
Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”